- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03373175
Assesment of Muscular Unloading in Chronic Obstructive Pulmonary Disease (COPD) Patients With NIV (EMGNIV)
August 3, 2021 updated by: Manel Lujan-Torne, Corporacion Parc Tauli
Influence of Ventilator Model and Pressure Support Level in Muscular Unloading in COPD Patients With Non Invasive Ventilation (NIV)
Evaluation of high intensity NIMV in terms of physiological parameters has been performed in short-term studies in COPD patients.
However, the support pressure levels used in exacerbated patients seem contradictory and the muscular unloading levels are uncertain.
The objective of study is to determine the discharge level of the inspiratory musculature reached at the same pressure support (PS) values in a group of hospital and domiciliary ventilators.
Patients with COPD in at least 6 months of treatment with home NIMV and in stable phase of their disease will be included.
Eight commercial ventilators will be used, each patient will use 2 different ventilators.
A 5 minute record will be taken at baseline (without NIMV).
Subsequently, 5 minutes in NIMV in 3 levels of PS (15/10/20) for each ventilator (15/10/20) and patient with expiratory positive airway pressure (EPAP) of 5 centimeters of water (cmH2O) will be recorded.
The results will be compared between the different ventilators and PS values using a general linear model for repeated variables to determine the differences between ventilators and PS levels of respiratory muscular unloading in COPD patients
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Madrid, Spain, 28041
- Hospital Universitario 12 de Octubre
-
-
Barcelona
-
Sabadell, Barcelona, Spain, 08208
- Hospital Parc Tauli
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with COPD diagnoses based on a spirometry performed the previous year during stability.
- COPD patients with home NIV treatment of at least 6 months with acceptable compliance and adaptation.
- Stable patients or just before hospital discharge due to an exacerbation with gasometric stability.
Exclusion Criteria:
- Respiratory acidosis in blood gas analysis, just in case of recent exacerbation
- Patients with restrictive pathology and /or obesity (IMC>35)
- Poor quality of EMG signals.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Ventilator 1 vs Ventilator 2
2 Ventilators will be evaluated for patient.
All parameters will be monitored and the differences will be analyzed.
Interventions: Basal record Pressure Support 10 (PS 10)record Pressure Support 15 (PS 15) record Pressure Support 20 (PS 20) record
|
Basal EMG record will be performed during 5 minutes.
This record must be the same in both ventilators.
PS 10 EMG record record will be performed during 5 minutes.
First with ventilator 1 and then with the other.
The patient must be rest at least 5 minutes to recover basal record
PS 15 EMG record record will be performed during 5 minutes.
First with ventilator 1 and then with the other.
The patient must be rest at least 5 minutes to recover basal record
PS 20 EMG record record will be performed during 5 minutes.
First with ventilator 1 and then with the other.
The patient must be rest at least 5 minutes to recover basal record
|
|
EXPERIMENTAL: Ventilator 3 vs Ventilator 4
2 Ventilators will be evaluated for patient.
All parameters will be monitored and the differences will be analyzed.Interventions: Basal record PS10 record PS15 record PS 20 record
|
Basal EMG record will be performed during 5 minutes.
This record must be the same in both ventilators.
PS 10 EMG record record will be performed during 5 minutes.
First with ventilator 1 and then with the other.
The patient must be rest at least 5 minutes to recover basal record
PS 15 EMG record record will be performed during 5 minutes.
First with ventilator 1 and then with the other.
The patient must be rest at least 5 minutes to recover basal record
PS 20 EMG record record will be performed during 5 minutes.
First with ventilator 1 and then with the other.
The patient must be rest at least 5 minutes to recover basal record
|
|
EXPERIMENTAL: Ventilator 5 vs Ventilator 6
2 Ventilators will be evaluated for patient.
All parameters will be monitored and the differences will be analyzed.
Interventions: Basal record PS10 record PS15 record PS 20 record
|
Basal EMG record will be performed during 5 minutes.
This record must be the same in both ventilators.
PS 10 EMG record record will be performed during 5 minutes.
First with ventilator 1 and then with the other.
The patient must be rest at least 5 minutes to recover basal record
PS 15 EMG record record will be performed during 5 minutes.
First with ventilator 1 and then with the other.
The patient must be rest at least 5 minutes to recover basal record
PS 20 EMG record record will be performed during 5 minutes.
First with ventilator 1 and then with the other.
The patient must be rest at least 5 minutes to recover basal record
|
|
EXPERIMENTAL: Ventilator 7 vs Ventilator 8
2 Ventilators will be evaluated for patient.
All parameters will be monitored and the differences will be analyzed.
Interventions: Basal record PS10 record PS15 record PS 20 record
|
Basal EMG record will be performed during 5 minutes.
This record must be the same in both ventilators.
PS 10 EMG record record will be performed during 5 minutes.
First with ventilator 1 and then with the other.
The patient must be rest at least 5 minutes to recover basal record
PS 15 EMG record record will be performed during 5 minutes.
First with ventilator 1 and then with the other.
The patient must be rest at least 5 minutes to recover basal record
PS 20 EMG record record will be performed during 5 minutes.
First with ventilator 1 and then with the other.
The patient must be rest at least 5 minutes to recover basal record
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Inspiratory muscular unloading (µv)
Time Frame: 1 day
|
Differences in parasternal electromyogram (EMG) signals interpretation between the record of ventilator 1 and ventilator 2.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Baseline EMG (µv) record
Time Frame: 1 day
|
Parasternal EMG signals interpretation before and without NIV.
Spontaneous breathing record.
The outcome measure inspiratory muscular effort of the patient in basal conditions.
|
1 day
|
|
Pressure support 10 EMG (µv) record. V1
Time Frame: 1 day
|
Parasternal EMG signals interpretation during first phase of NIV, in this case it will be programmed at 10 cmH2O os pressure support (PS) with Ventilator 1 during 5 minutes.
|
1 day
|
|
Pressure support 15 EMG (µv) record. V1
Time Frame: 1 day
|
Parasternal EMG signals interpretation during the second phase of NIV that will be programmed at 15 cmH2O os pressure support (PS) with Ventilator 1 during 5 minutes
|
1 day
|
|
Pressure support 20 EMG (µv) record. V1
Time Frame: 1 day
|
Parasternal EMG signals interpretation during the last phase of NIV that will be programmed at 20 cmH2O os pressure support (PS) with Ventilator 1 during 5 minutes
|
1 day
|
|
Pressure support 10 EMG (µv) record. V2
Time Frame: 1 day
|
Paraesternal EMG signals interpretation during the last phase of NIV that will be programmed at 10 cmH2O os pressure support (PS) with Ventilator 2 during 5 minutes
|
1 day
|
|
Pressure support 15 EMG (µv) record. V2
Time Frame: 1 day
|
Parasternal EMG signals interpretation during the last phase of NIV that will be programmed at 15 cmH2O os pressure support (PS) with Ventilator 2 during 5 minutes
|
1 day
|
|
Pressure support 20 EMG (µv) record. V2
Time Frame: 1 day
|
Parasternal EMG signals interpretation during the last phase of NIV that will be programmed at 20 cmH2O os pressure support (PS) with Ventilator 2 during 5 minutes
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Manel Lujan, MD, Corporacion Parc Tauli (Sabadell, Barcelona)
- Principal Investigator: Javier Sayas, Hospital Universitario 12 De Octubre (Madrid)
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 30, 2017
Primary Completion (ACTUAL)
October 30, 2020
Study Completion (ACTUAL)
May 3, 2021
Study Registration Dates
First Submitted
December 11, 2017
First Submitted That Met QC Criteria
December 11, 2017
First Posted (ACTUAL)
December 14, 2017
Study Record Updates
Last Update Posted (ACTUAL)
August 4, 2021
Last Update Submitted That Met QC Criteria
August 3, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 2017632
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COPD
-
University Medical Center GroningenCompleted
-
Ryme Medical, Inc.Not yet recruitingCOPD | Lung Disease, Chronic Obstructive | COPD Patients | COPD Acute Exacerbation | COPD (Chronic Obstructive Pulmonary Disease) | Lung Disease Airways | COPD Exacerbations
-
Insel Gruppe AG, University Hospital BernUniversity Hospital, Geneva; Cantonal Hospital St. Gallen, SwitzerlandNot yet recruiting
-
Istituto Nazionale di Ricovero e Cura per AnzianiRecruiting
-
Bio-Sensing Solutions S.L. (DyCare)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Centre...Recruiting
-
Sir Run Run Shaw HospitalRecruiting
-
The First Affiliated Hospital of Guangzhou Medical...Recruiting
-
Association des Réseaux BronchioliteLaboratoire Système et Matériaux pour la Mécatronique (SYMME)Recruiting
-
Polytechnic Institute of PortoNippon Gases PortugalRecruiting
-
China-Japan Friendship HospitalNot yet recruiting
Clinical Trials on Basal record
-
Tanta UniversityCompletedInsulin | Diabetic Ketoacidosis | Intensive Care Unit StayEgypt
-
Cairo UniversityCompleted
-
Regend TherapeuticsSouthwest Hospital, China; Tongji UniversityCompletedChronic Obstructive Pulmonary DiseaseChina
-
First Affiliated Hospital of Shantou University...Regend Therapeutics; Tongji UniversityUnknownChronic Obstructive Pulmonary DiseaseChina
-
Nanfang Hospital of Southern Medical UniversityRegend Therapeutics; Tongji UniversityUnknownChronic Obstructive Pulmonary DiseaseChina
-
Regend TherapeuticsSouthwest Hospital, China; Tongji UniversityUnknownBronchiectasisChina
-
Regend TherapeuticsThe First Affiliated Hospital of Soochow UniversityUnknownChronic Respiratory DiseaseChina
-
Ruijin HospitalRegend TherapeuticsUnknown
-
Naama ConstantiniCompleted
-
BioSerenityUnknownHealthy Volunteers Without Any Cardiac or Any Neurological DisordersFrance